6-115968725-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_002031.3(FRK):c.481G>A(p.Val161Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000651 in 1,612,788 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002031.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FRK | NM_002031.3 | c.481G>A | p.Val161Ile | missense_variant | 3/8 | ENST00000606080.2 | NP_002022.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FRK | ENST00000606080.2 | c.481G>A | p.Val161Ile | missense_variant | 3/8 | 1 | NM_002031.3 | ENSP00000476145.1 | ||
ENSG00000289376 | ENST00000692859.2 | n.223-66547G>A | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.000348 AC: 53AN: 152116Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000560 AC: 14AN: 250124Hom.: 0 AF XY: 0.0000370 AC XY: 5AN XY: 135122
GnomAD4 exome AF: 0.0000356 AC: 52AN: 1460554Hom.: 0 Cov.: 30 AF XY: 0.0000413 AC XY: 30AN XY: 726490
GnomAD4 genome AF: 0.000348 AC: 53AN: 152234Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74440
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 26, 2024 | The c.481G>A (p.V161I) alteration is located in exon 3 (coding exon 3) of the FRK gene. This alteration results from a G to A substitution at nucleotide position 481, causing the valine (V) at amino acid position 161 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at